Professor of Clinical Trials at The Institute of Cancer Research, London

Judith Bliss is Professor of Clinical Trials at The Institute of Cancer Research, London, Director of its Cancer Research UK funded Clinical Trials & Statistics Unit (ICR-CTSU) and an NIHR Senior Investigator. A trials statistician with over 35 years’ experience in design and analysis of cancer clinical trials, driven by a desire that trials are efficient and sufficiently robust to provide results to directly influence routine clinical practice internationally. She is currently chair of UK Breast Intergroup, member of NCRI Breast Cancer Research Group (Chair of its Early Disease Subgroup). Internationally, she is a member of the Executive Board of the Breast International Group (BIG) and EBCTCG Steering Committee member. Her methodology research interests focus on increasing trial efficiency and enabling technology to enhance trial conduct including accessing routine data on cancer outcomes. She is a member of Trials Methodology Research Partnership Health Informatics Strategy Group.  Her focus for contemporary trial activity is on establishing evidence for targeted therapies utilising biologically defined intermediate endpoints to drive therapeutic choices, risk adaptation and to predict outcomes. She collaborates with key clinical and scientific opinion leaders and pharmaceutical company partners as required.  In 2021 she was successful in renewing her NIHR Senior Investigator Award recognising her trials leadership, contribution to UK clinical research and impact on patient outcomes. She has published over 200 peer-review papers, largely on breast cancer trials and is the statistical lead for numerous trials (including POETIC-A, HER2-RADiCAL, PHOENIX, FAST-FORWARD, POETIC, TACT2, START, IMPORT, EPHOS, IES, PALLET, plasmaMATCH, c-TRAK TN).